← Back to Search

Depression Subjects: Influenza Vaccine for Depression

Phase 4
Waitlist Available
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This study is evaluating whether the immune system of depressed individuals is different from that of healthy individuals.

Eligible Conditions
  • Depression
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Positive and Negative Affect Schedules Score
Secondary outcome measures
Cytokine
Difference in PGE4/LipoxinA4 Ratio
HPA Axis
+1 more
Other outcome measures
Fold Change

Side effects data

From 2015 Phase 4 trial • 985 Patients • NCT02290691
64%
Tenderness
48%
Pain
35%
Redness
29%
Swelling
24%
Itching
20%
Muscle Ache
15%
Headache
12%
Fatigue
10%
Bruising
5%
Chills
4%
Nausea
1%
Vomiting
1%
Fever
100%
80%
60%
40%
20%
0%
Study treatment Arm
Needle- Free
Needle and Syringe

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Depression Subjects: Influenza VaccineExperimental Treatment1 Intervention
Subjects will receive a quadrivalent inactivated influenza vaccine, for the appropriate season/year of enrollment. The vaccine will be administered by the PI or similarly trained clinician, into the deltoid muscle as directed
Group II: Healthy Subjects: Influenza VaccineActive Control1 Intervention
Subjects will receive a quadrivalent inactivated influenza vaccine, for the appropriate season/year of enrollment. The vaccine will be administered by the PI or similarly trained clinician, into the deltoid muscle as directed
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Influenza Vaccine
2010
Completed Phase 4
~6900

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,169 Total Patients Enrolled
30 Trials studying Depression
5,204 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression
2019. "Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03756246.
All > Experimental
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top